Abstract:The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system, an RNA-guided nuclease for specific genome editing in vivo, has been adopted in a wide variety of organisms. In contrast, the in vitro application of the CRISPR/Cas9 system has rarely been reported. We present here a highly efficient in vitro CRISPR/Cas9-mediated editing (ICE) system that allows specific refactoring of biosynthetic gene clusters in Streptomyces bacteria and other large DNA fragments. Cleavage by Cas9 of circular pUC18 DNA was investigated here as a simple model, revealing that the 3'→5' exonuclease activity of Cas9 generates errors with 5 to 14 nucleotides (nt) randomly missing at the editing joint. T4 DNA polymerase was then used to repair the Cas9-generated sticky ends, giving substantial improvement in editing accuracy. Plasmid pYH285 and cosmid 10A3, harboring a complete biosynthetic gene cluster for the antibiotics RK-682 and holomycin, respectively, were subjected to the ICE system to delete the rkD and homE genes in frame. Specific insertion of the ampicillin resistance gene (bla) into pYH285 was also successfully performed. These results reveal the ICE system to be a rapid, seamless, and highly efficient way to edit DNA fragments, and a powerful new tool for investigating and engineering biosynthetic gene clusters. Importance: Recent improvements in cloning strategies for biosynthetic gene clusters promise rapid advances in understanding and exploiting natural products in the environment. For manipulation of such biosynthetic gene clusters to generate valuable bioactive compounds, efficient and specific gene editing of these large DNA fragments is required. In this study, a highly efficient in vitro DNA editing system has been established. When combined with end repair using T4 DNA polymerase, Cas9 precisely and seamlessly catalyzes targeted editing, including in-frame deletion or insertion of the gene(s) of interest. This in vitro CRISPR editing (ICE) system promises a step forward in our ability to engineer biosynthetic pathways.

Hypercompact TnpB and truncated TnpB systems enable efficient genome editing in vitro and in vivo

Evolutionary mining and functional characterization of TnpB nucleases identify efficient miniature genome editors

Genome editing in plants using the TnpB transposase system

Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted ωRNAs

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editing

Current status of genome editing technologies: special issue of BMB Reports in 2024

Development of a Versatile Nuclease Prime Editor with Upgraded Precision

Genome-Editing Technologies: Principles and Applications.

Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications

Characterization the gene editing with miniature nucleases TnpB, IscB and enIscB in Escherichia coli strains

Expanding the editable genome and CRISPR–Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking

To Cut or Not to Cut: Next-generation Genome Editors for Precision Genome Engineering

Compact zinc finger architecture utilizing toxin-derived cytidine deaminases for highly efficient base editing in human cells

Transcription-coupled Donor DNA Expression Increases Homologous Recombination for Efficient Genome Editing

A TALE nuclease architecture for efficient genome editing

Rapidly evolving genome and epigenome editing technologies

Flexible TAM requirement of TnpB enables efficient single-nucleotide editing with expanded targeting scope

Transcription Activator‐like Effector Nucleases (talens): A Highly Efficient and Versatile Tool for Genome Editing

In Vitro CRISPR/Cas9 System for Efficient Targeted DNA Editing